Researchers are testing a new experimental cancer treatment that uses ultrasound waves and microscopic gas-filled bubbles to destroy breast cancer cells with minimal harm to surrounding healthy tissue.

The approach, reported in research highlighted by the American Chemical Society, involves injecting tiny microbubbles into the bloodstream near a tumor. When exposed to focused ultrasound energy, the bubbles rapidly expand and collapse, creating mechanical forces capable of damaging cancer cells and disrupting tumor blood vessels.

Scientists say this process — known as ultrasound-triggered cavitation — may also improve the delivery of anti-cancer drugs directly into tumors, potentially increasing treatment effectiveness while reducing systemic side effects commonly associated with chemotherapy and radiation therapy.

Early laboratory and pre-clinical studies have shown encouraging outcomes, suggesting the method could become a non-invasive treatment option requiring shorter recovery times compared with conventional cancer procedures. Researchers stress that the technology is still under development and must undergo human clinical trials before routine medical use.

Breast cancer remains the most frequently diagnosed cancer worldwide, with roughly 2.3 million new cases recorded each year. Millions of patients currently undergo surgery, chemotherapy or radiation annually, driving global efforts to develop safer, more targeted therapies.

Experts believe ultrasound-activated microbubble therapy represents part of a broader shift toward precision oncology — treatments designed to attack tumors directly while preserving healthy tissue — though further research is needed to confirm long-term safety and effectiveness.